A Study of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis

Study Identifier
M02-575
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Results Available

Scientific Result Summary
Available Language(s): English

Study Details

Medical Condition
  • Rheumatoid Arthritis
  • Study Drug
  • adalimumab
  • placebo
  • Phase
    CSR.ORG
    Sex
    Female & Male
    Age
    20+ years

    Protocol Summary

    The primary objective of this study is to evaluate the safety, efficacy and pharmacokinetics

    of three doses of adalimumab in adult Japanese subjects with RA

    Study Locations

    Location
    Status
    Location
    Aichi, Japan
    Status
    Not applicable
    Location
    Chiba, Japan
    Status
    Not applicable
    Location
    Ehime, Japan
    Status
    Not applicable
    Location
    Fukui, Japan
    Status
    Not applicable
    Location
    Fukuoka, Japan
    Status
    Not applicable
    Location
    Gunma, Japan
    Status
    Not applicable
    Showing {first} - {last} of {total} Results